Canada Pension Plan Investment Board Atara Biotherapeutics, Inc. Transaction History

Canada Pension Plan Investment Board

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$4.69 - $9.84 $487,760 - $1.02 Million	-104,000 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$8.44 - $16.89 $658,320 - $1.32 Million	-78,000 Reduced 42.86%	104,000 $966,000
Q4 2021 Feb 14, 2022	SELL	$14.7 - $19.89 $161,700 - $218,790	-11,000 Reduced 5.7%	182,000 $2.87 Million
Q3 2021 Nov 15, 2021	BUY	$11.99 - $17.9 $1.25 Million - $1.86 Million	104,000 Added 116.85%	193,000 $3.46 Million
Q2 2021 Aug 16, 2021	BUY	$12.89 - $16.58 $38,670 - $49,739	3,000 Added 3.49%	89,000 $1.38 Million

Q1 2021 May 17, 2021	SELL	$14.0 - $20.72 $4.14 Million - $6.13 Million	-296,000 Reduced 77.49%	86,000 $1.24 Million
Q4 2020 Feb 17, 2021	SELL	$12.67 - $26.23 $12.7 Million - $26.2 Million	-1,000,041 Reduced 72.36%	382,000 $7.5 Million
Q3 2020 Nov 12, 2020	SELL	$11.92 - $15.87 $885,977 - $1.18 Million	-74,327 Reduced 5.1%	1,382,041 $17.9 Million
Q2 2020 Aug 14, 2020	SELL	$7.53 - $14.93 $2.59 Million - $5.13 Million	-343,632 Reduced 19.09%	1,456,368 $21.2 Million
Q4 2019 Feb 14, 2020	BUY	$10.89 - $16.79 $19.4 Million - $29.9 Million	1,778,545 Added 8289.65%	1,800,000 $29.6 Million
Q3 2019 Nov 12, 2019	BUY	$12.03 - $19.94 $258,103 - $427,812	21,455 New	21,455 $303,000
Q2 2019 Aug 12, 2019	SELL	$19.05 - $41.04 $373,380 - $804,384	-19,600 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$28.4 - $41.74 $4.9 Million - $7.2 Million	-172,500 Reduced 89.8%	19,600 $779,000
Q4 2018 Feb 06, 2019	BUY	$30.9 - $42.97 $5.94 Million - $8.25 Million	192,100 New	192,100 $6.67 Million

85M

18.4K

51.3K

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $728M
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

Get notified when there are updates to the investment portfolio of Canada Pension Plan Investment Board, based on Form 13F filings with the SEC.

Stay updated on Canada Pension Plan Investment Board with notifications on news.